GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (FRA:2HQ) » Definitions » Buyback Yield %

Tilray Brands (FRA:2HQ) Buyback Yield % : 0.00 (As of May. 01, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tilray Brands Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Tilray Brands's current buyback yield was 0.00%.


Tilray Brands Buyback Yield % Historical Data

The historical data trend for Tilray Brands's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Buyback Yield % Chart

Tilray Brands Annual Data
Trend Aug14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.89 -6.33 -1.33 -10.41 -10.47

Tilray Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tilray Brands's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Tilray Brands's Buyback Yield % falls into.



Tilray Brands Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Tilray Brands's Buyback Yield for the fiscal year that ended in May. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-1.094 + 119.226) / 1128.13329
=-10.47%

Tilray Brands's annualized Buyback Yield for the quarter that ended in Feb. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 / 1253.92536
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Feb. 2024) data.


Tilray Brands Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands (FRA:2HQ) Business Description

Traded in Other Exchanges
Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.

Tilray Brands (FRA:2HQ) Headlines

No Headlines